Sanford Rose Recruits CEO for IDS

November 14, 2011 – Sanford Rose Associates’ San Diego office has placed Dr. Peter Bambic as CEO and GM at Immunodiagnostic Systems, Inc. (IDS). Dr. Bambic joins IDS after serving most recently as CEO of Adaltis, Inc. IDS is a company producing diagnostic testing kits for the clinical and research markets and with a focus on manual and automated immunoassays used in the area of bone disease, growth, and hypertension. Sanford Rose Associates’ San Diego office provides specialized in building management teams for personalized medicine, molecular diagnostic and oncology companies.